<DOC>
	<DOCNO>NCT01400971</DOCNO>
	<brief_summary>The purpose study identify specific patient , physician , health system related factor associate progression intensive regimen initial insulin therapy patient type 2 diabetes .</brief_summary>
	<brief_title>An Observational Study Understand Challenges Associated With Progression Insulin Therapy Type 2 Diabetes</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Disease Progression</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<criteria>Have diagnose type 2 diabetes Have present within normal course care Have initial insulin therapy â‰¥3 month ( without combination approve noninsulin antidiabetic medication ) Are simultaneously participate study include investigational drug procedure entry study Have fully inform give write consent use data Have sufficient understanding primary language country able complete questionnaire Have initiate basal bolus therapy ( three mealtime insulin injection )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2015</verification_date>
	<keyword>Diabetes</keyword>
	<keyword>Insulin</keyword>
	<keyword>Progression</keyword>
	<keyword>Patient Reported Measures</keyword>
	<keyword>Adherence</keyword>
	<keyword>Heterogeneity</keyword>
	<keyword>Hypoglycemia</keyword>
</DOC>